Mapping and predicting mortality from systemic sclerosisMuriel Elhaï, Carlos Alberto von Mühlen, László Czirják et al.|Annals of the Rheumatic Diseases|2017Cited by 699
Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for ScreeningMaria Grazia Lazzaroni, Ilaria Cavazzana, Enrico Colombo et al.|The Journal of Rheumatology|2017Cited by 127
Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensusFrancesca Ingegnoli, Valentina Messiniti, Ariane L. Herrick et al.|Lara D. Veeken|2020Cited by 41
Identification of novel genetic markers associated with the clinical phenotypes of systemic sclerosis through a genome wide association strategyOlga Y. Gorlova, A T Lee, J M Martin et al.|Journal of Translational Medicine|2010Cited by 32
Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European study (EUSTAR) (vol 37, pg 1673, 2010)Behrooz Z. Alizadeh, Timothy R. D. J. Radstake, J. Broen et al.|University of Groningen research database (University of Groningen / Centre for Information Technology)|2010Cited by 0